Tuesday, April 21, 2020 12:53:49 PM
Recent NBY News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/08/2024 10:31:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:13:00 PM
- NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results • Business Wire • 11/07/2024 09:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2024 09:58:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:46:28 PM
- NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price • Business Wire • 11/06/2024 09:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/29/2024 12:19:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 12:15:10 PM
- NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC • Business Wire • 10/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:27:16 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 10/16/2024 08:19:35 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 09/25/2024 09:17:41 PM
- Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm • PR Newswire (US) • 09/23/2024 01:27:00 PM
- Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals • PR Newswire (US) • 09/20/2024 12:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/20/2024 12:08:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:08:15 PM
- NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets • Business Wire • 09/20/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:11:02 PM
- NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results • Business Wire • 08/13/2024 08:05:00 PM
- NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024 • Business Wire • 08/01/2024 10:50:00 AM
- NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales • Business Wire • 07/30/2024 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 08:25:15 PM
- NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option • Business Wire • 07/29/2024 08:05:00 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 07/26/2024 09:19:56 PM
- NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering • Business Wire • 07/26/2024 12:30:00 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM